IFP Advisors, Inc

Position in CTXR — Citius Pharmaceuticals, Inc.

CIK 1641866 TAMPA, FL

Position in CTXR

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$2,530

-$3,844 QoQ

Shares Held

4,183

-40.9% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#25

of 43 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

IFP Advisors, Inc holds $55,990,065 across 216 Biotechnology names. CTXR ranks #125 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	62,273	$15,242,562
2	TGTX	Tg Therapeutics, Inc.	209,318	$11,499,930
3	JAZZ	Jazz Pharmaceuticals plc	34,193	$8,239,487
4	AUPH	Aurinia Pharmaceuticals Inc.	361,634	$6,136,928
5	VKTX	Viking Therapeutics, Inc.	61,616	$2,403,640
6	EXEL	Exelixis, Inc.	43,101	$2,345,125
7	VRTX	Vertex Pharmaceuticals Inc / Ma	2,968	$1,474,294
8	REGN	Regeneron Pharmaceuticals, Inc.	1,352	$843,026

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,530	4,183	-40.9%	Shares	Sole	2026-07-20
2026-03-31	$6,374	7,083	0.0%	Shares	Sole	2026-04-13
2025-12-31	$5,503	7,083	0.0%	Shares	Sole	2026-02-06
2025-09-30	$8,782	7,083	0.0%	Shares	Sole	2026-02-06
2025-06-30	$11,261	7,083	0.0%	Shares	Sole	2025-07-24
2025-03-31	$10,553	7,083	-82.5%	Shares	Sole	2025-05-05
2024-12-31	$32,782	40,416	+21.2%	Shares	Sole	2025-02-04
2024-09-30	$16,699	33,333	+17443.7%	Shares	Sole	2025-02-04
2022-12-31	$1	190	0.0%	Shares	Sole	2023-02-07
2022-09-30	$229	190	0.0%	Shares	Sole	2022-11-08
2022-06-30	$174	190	0.0%	Shares	Sole	2022-09-06
2022-03-31	$340	190	—	Shares	Sole	2022-09-06
No filing history on record for this holder in this stock.